Cirdan
PrivateLast Round
VC Round
Apr 14, 2026
Est. Valuation
$13.14M
Total Funding Raised
$12.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cirdan is a healthcare technology company that provides laboratory information systems (LIS) and imaging solutions to accelerate and enhance diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cirdan Comparables
Compare Cirdan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CrelioHealth | 83% | |
| Lumea | 82% | |
| NovoPath | 79% |
Cirdan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 14, 2026 | ||||
| Growth Equity | Oct 15, 2024 | ||||
| VC Round | Oct 12, 2023 | ||||
| Debt | Feb 18, 2020 | ||||
| VC Round | Feb 4, 2016 | ||||
VC Round | Feb 23, 2015 |
Cirdan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Salica Investments | VC Round |
| QUBIS | Seed |
| Kernel Capital | Growth Equity, VC Round |
| Whiterock Finance | Debt |
| British Business Bank | Debt, Growth Equity, VC Round |
| Invest Northern Ireland | Debt, Seed |
| 57 Stars | Growth Equity, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
$5M raised in a venture debt round.
- Jan 14, 2026
Platform now FHIR-ready, supporting modern healthcare integration standards.
Recent news
Latest coverage and updates
- hiresJul 20, 2026
Cirdan Ltd hired Enya Saul as Lab Analyst on Jul 20th '26.
Cirdan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cirdan's valuation, stock price, and market status.
Is Cirdan a public or private company?
Cirdan is a private company.
What is the current stock price of Cirdan?
Cirdan is a private company with no public stock price. No recent secondary market data is available.
How much is Cirdan worth (valuation)?
Cirdan's valuation is estimated at $13.1M based on funding round data.
Can I buy Cirdan stock?
Cirdan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cirdan's last funding round?
Cirdan's most recent funding round was Debt on February 4, 2016.
Who are the main investors in Cirdan?
Key investors in Cirdan include Kernel Capital, Whiterock Finance, Clarendon Fund Managers, Hambro Perks Ltd..
Will Cirdan IPO soon?
No public IPO plans have been announced for Cirdan.
How can I track Cirdan secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cirdan's secondary market activity and sign up for updates.